Red
Brand Name(s):Yervoy
Indication:Melanoma – advanced (unresectable or metastatic) in adults and adolescents 12 years of age and older who have received prior therapy.
Renal Cell Carcinoma (RCC)
Rationale:1,2,3
Considered:Jul-11
Review Date:Feb-24
Comments:
Drug Safety Update
Ipilimumab (Yervoy): reports of cytomegalovirus (CMV) gastrointestinal infection or reactivation
Jan 2019